pavani vupparapalli's most recent trade in Novelix Pharmaceuticals Ltd. was a Acquisition of 400,000 Equity Shares done at an average price of Rs. 10 . Disclosure was reported to the exchange on June 26, 2024 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for pavani vupparapalli in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trimurthi | Vupparapalli Pavani (Revised) | Promoter Group | Acquisition | 26 Jun 2024 | 400,000 | 400,000 (4.02%) | 4.94% | 10 | 4,000,000 | 11 Jun 2024 11 Jun 2024 |
Insider Trading | Equity Shares | Preferential Offer |
| Trimurthi | Vupparapalli Pavani | Promoter Group | Acquisition | 12 Jun 2024 | 400,000 | 400,000 (4%) | 4.94% | 10 | 4,000,000 | 11 Jun 2024 11 Jun 2024 |
Insider Trading | Equity Shares | Preferential Offer |